Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | LIPE | Q05469 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 2/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8682165 | 1.00 | POLB (0.37) | POLBCHRM1LIPECHRM2CHRM4 | |
| SCHEMBL8682108 | 0.98 | POLB (0.36) | POLBCHRM1LIPE | |
| SCHEMBL13529058 | 0.90 | — | — | |
| SCHEMBL15413270 | 0.76 | ALDH1A1 (0.33) | POLBLIPECHRNA7 | |
| SCHEMBL27699290 | 0.76 | MAPT (0.36) | LIPE | |
| SCHEMBL6559583 | 0.76 | SMN1; SMN2 (0.40) | POLBACHEBCHE | |
| SCHEMBL8681060 | 0.76 | EPHX1 (0.44) | POLBCHRNB2MAPK1CHRNA4ACHE | |
| SCHEMBL8681065 | 0.76 | EPHX1 (0.44) | POLBCHRNB2MAPK1CHRNA4ACHE | |
| SCHEMBL27558387 | 0.74 | LIPE (0.33) | POLBLIPE | |
| SCHEMBL27519967 | 0.74 | MAPT (0.39) | POLBLIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108573816-B | Organic electrolyte for super capacitor and super capacitor | 深圳新宙邦科技股份有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-108573816-B | Organic electrolyte for super capacitor and super capacitor | 深圳新宙邦科技股份有限公司 | 2020-07-10 | — | — | CN | disclosed |
| CN-108573816-A | Organic electrolyte and ultracapacitor for ultracapacitor | 深圳新宙邦科技股份有限公司 | 2018-09-25 | — | — | CN | disclosed |
| US-5843983-A | Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use | SANKYO COMPANY, LIMITED (JP) | 1998-12-01 | — | — | US | disclosed |
| EP-0844000-A1 | Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis | SANKYO COMPANY LIMITED (JP) | 1998-05-27 | — | — | EP | disclosed |
| EP-0790235-A1 | Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses | SANKYO COMPANY LIMITED (JP) | 1997-08-20 | — | — | EP | disclosed |
| US-5556864-A | TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |